Changes in PD-L1 Expression Modify IBD-CMF-Mediated Regulation of Tbet and IFN-γ Production by CD3/CD28-Activated and Differentiated Th1 CD4+ T Cells. This evidence concerns the gene CD274 and inflammatory bowel disease.